These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36831406)

  • 21. Second-line chemotherapy in biliary tract cancer: Outcome and prognostic factors.
    Schweitzer N; Kirstein MM; Kratzel AM; Mederacke YS; Fischer M; Manns MP; Vogel A
    Liver Int; 2019 May; 39(5):914-923. PubMed ID: 30716200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index.
    Rovesti G; Leone F; Brandi G; Fornaro L; Scartozzi M; Niger M; Yoo C; Caputo F; Filippi R; Casagrande M; Silvestris N; Santini D; Faloppi L; Palloni A; Aglietta M; Vivaldi C; Cho H; Lai E; Fenocchio E; Nichetti F; Pella N; De Lorenzo S; Di Maio M; Vasile E; de Braud F; Jeong JH; Aprile G; Orsi G; Cascinu S; Casadei-Gardini A
    J Gastrointest Cancer; 2022 Jun; 53(2):289-298. PubMed ID: 33544375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.
    Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW
    Ann Oncol; 2016 Jan; 27(1):134-40. PubMed ID: 26483051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance.
    Ahn DH; Javle M; Ahn CW; Jain A; Mikhail S; Noonan AM; Ciombor K; Wu C; Shroff RT; Chen JL; Bekaii-Saab T
    Cancer; 2016 Dec; 122(23):3657-3666. PubMed ID: 27495988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
    Loosen SH; Ulmer TF; Labuhn S; Bednarsch J; Lang SA; Alizai PH; Schneider AT; Vucur M; Neumann UP; Luedde T; Roderburg C
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prediction model for survival in patients with biliary tract cancer: a development and validation study].
    Han L; Cui P; Tang MS; Zhang M; Cui HJ; Zeng ZQ; Chen SY; Liu SS; Song B; Gu DQ; Wang X; Zhang B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1461-1469. PubMed ID: 31838822
    [No Abstract]   [Full Text] [Related]  

  • 27. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer.
    Branchi V; Esser L; Boden C; Jafari A; Henn J; Lingohr P; Gonzalez-Carmona MA; Schmitz M; Weismüller TJ; Strassburg CP; Manekeller S; Kristiansen G; Kalff JC; Matthaei H; Toma MI
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival.
    Ma L; Qiu J; Zhang Y; Qiu T; Wang B; Chen W; Li X; Sun J; Wang K; Li X; Gu Y; Shu Y; Chen X
    Onco Targets Ther; 2018; 11():2533-2543. PubMed ID: 29765232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
    Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction Efficacy for Clinical Outcome of Prognostic Nutritional Index in Patients with Resectable Biliary Tract Cancer Depends on Sex and Obstructive Jaundice Status.
    Wang J; Bo X; Li M; Nan L; Wang C; Gao Z; Suo T; Ni X; Liu H; Han J; Lu P; Liu H; Wang Y
    Ann Surg Oncol; 2021 Jan; 28(1):430-438. PubMed ID: 32548755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
    Kim H; Kim JY; Park KU
    Oncology; 2023; 101(1):41-48. PubMed ID: 36257294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.
    Suzuki Y; Kan M; Kimura G; Umemoto K; Watanabe K; Sasaki M; Takahashi H; Hashimoto Y; Imaoka H; Ohno I; Mitsunaga S; Ikeda M
    J Gastroenterol; 2019 Mar; 54(3):281-290. PubMed ID: 30298469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
    Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
    Front Oncol; 2022; 12():863094. PubMed ID: 35619909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
    Filippi R; Montagnani F; Lombardi P; Fornaro L; Aprile G; Casadei-Gardini A; Faloppi L; Palloni A; Satolli MA; Scartozzi M; Citarella F; Lutrino SE; Vivaldi C; Silvestris N; Rovesti G; Rimini M; Aglietta M; Brandi G; Leone F
    Acta Oncol; 2021 Oct; 60(10):1317-1324. PubMed ID: 34282710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
    McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW
    J Hepatol; 2020 Nov; 73(5):1109-1117. PubMed ID: 32446715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study.
    Berardi R; Mocchegiani F; Rinaldi S; Fiordoliva I; Rovinelli F; Caramanti M; Federici A; Burattini M; Morgese F; Torniai M; Marcantognini G; Vivarelli M
    Oncol Ther; 2020 Jun; 8(1):115-124. PubMed ID: 32700076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.